Dr. Rodrigo Gil, Dr. Mauricio Salinas, Dra. Mónica Zagolín y Dr. Matías Florenzano.
Participantes:
Becados de Enfermedades Respiratorias Universidad de Chile, en el Instituto Nacional del Tórax.
Descripción:
Espacio destinado a revisar en forma crítica publicaciones médicas en el área de Enfermedades Respiratorias, basado en reuniones semanales en modalidad en línea.
Objetivo general:
Presentar en forma concisa publicaciones en el área de Enfermedades Respiratorias que nos hayan parecido novedosas y de impacto clínico Esquema de la reunión: pregunta de la investigación, diseño del estudio, criterios de inclusión, intervenciones, desenlaces y resultados. Posteriormente se analiza el impacto del estudio en la práctica clínica y se discuten sus características metodológicas.
Publicación de Presentaciones :
Algunas reuniones son publicadas como un resumen el que se puede revisar en el enlace respectivo
Complete el formulario y recibirá por correo un enlace que le permitirá ingresar a todas las reuniones, las que se realizan todos los días miércoles de 16:00 a 17:15 horas.
Miércoles 4 enero 2023 / 16:00 a 17:15 horas
Fernando J. Martinez. Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med Vol 203, Iss 5, pp 553–564, Mar 1, 2021.
Presenta el Dr. Miljenko Lolas
Miércoles 11 de enero / 16:00 a 17:15 horas
Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level
meta-analysis. Thorax 2021;76:582–59. Preoperative transthoracic lung biopsy was associated with increased pleural recurrence in stage I lung cancer and reduced survival in patients younger than 55 years.
Presenta: Dra. María Belén Fernandez
Miércoles 18 de enero / 16:00 a 17:15 horas
Association of Influenza Vaccination With Cardiovascular Risk AMeta-analysis
Presenta: Dr. Felipe Cayupi
Miércoles 25 de enero / 16:00 a 17:15 horas
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease. Eur Respiratory J 2019.
Presenta: Dr. Max Kauffmann
MARZO 2023
Miércoles 08 de marzo / 16:00 a 17:15 horas
Spencer S, Donovan T, Chalmers JD, et al. Intermittent prophylactic antibiotics for bronchiectasis. Cochrane Database of Systematic Reviews 2022
Presenta: Dra. Camila Díaz
Miércoles 15 de marzo / 16:00 a 17:15 horas
Association Between Preserved Ratio Impaired Spirometry (PRISm) and Clinical Outcomes in US Adults. JAMA. 2021;326(22):2287-2298.
In a large, population-based sample of US adults, baseline PRISm, compared with normal spirometry, was associated with a small but statistically
significant increased risk for mortality and adverse cardiovascular and respiratory outcomes.
Presenta: Dra. María Belén Fernandez
ABRIL 2023
Miércoles 12 de abril / 16:00 a 17:15 horas
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. J Clin Oncol 39:2574-2585. 2021
Presenta: Dra. María Fernanda Muñoz Bravo
Miércoles 26 de abril / 16:00 a 17:15 horas
Characterization of Eosinophilic Bronchiectasis. A European Multicohort Study. Am J Respir Crit Care Med Vol 205, Iss 8, pp 894–902, Apr 15, 2022
Eosinophilic bronchiectasis affects approximately 20% of patients. After accounting for infection status, raised blood eosinophil counts are associated with shortened time to exacerbation.
Presenta: Dr. Max Kauffmann
MAYO 2023
Miércoles 03 de mayo / 16:00 a 17:15 horas
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial”. Nivolumab represents a treatment that might be beneficial to patients with malignant mesothelioma who have progressed on first-line therapy
Presenta la Dra. Valentina Ibañez
Miércoles 10 de mayo / 16:00 a 17:15 horas
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea. A Randomized Controlled Trial
Presenta la Dra. María Belén Fernandez
Miércoles 17 de mayo / 16:00 a 17:15 horas
Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017. JAMA Intern Med. 2023;183(1):40-47. doi:10.1001/jamainternmed.2022.5472
Presenta la Dra. Nicole Fritzsche
Miércoles 24 de mayo / 16:00 a 17:15 horas
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer COG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022; 399: 1607–17
Presenta la Dra. María José Corrales
Miércoles 31 de mayo / 16:00 a 17:15 horas
Nathan C. Dean, Caroline G. Vines, Jason R. Carr et al. A Pragmatic, Stepped-Wedge, Cluster-controlled Clinical Trial of Real-Time Pneumonia Clinical Decision Support. Am J Respir Crit Care Med Vol 205, Iss 11, pp 1330–1336, Jun 1, 2022
Conclusions: ePNa deployment was associated with improved processes of care and lower mortality.
Presenta el Dr. Javier Riquelme
